Singular Genomics Systems, Inc. Common Stock

OMIC Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
OMIC Income Statement
OMIC Balance Sheet
OMIC Cash Flow
Congress Trading

Recent trades of OMIC by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
OMIC Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
OMIC Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
OMIC Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard
Insider Trading

Quarterly net insider trading by OMIC's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Corporate Lobbying

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Manipulating and detecting biological samples Dec. 03, 2024
  • Patent Title: Nucleotide analogues Nov. 19, 2024
  • Patent Title: Methods of sequencing circular template polynucleotides Nov. 12, 2024
  • Patent Title: Polynucleotide barcodes for long read sequencing Nov. 12, 2024
  • Patent Title: Sample cartridge Nov. 05, 2024
  • Patent Title: Reagent cartridge Oct. 29, 2024
  • Patent Title: Linked paired strand sequencing Oct. 22, 2024
  • Patent Title: Methods for long read sequencing Oct. 22, 2024
  • Patent Title: Methods and compositions for reducing nucleotide impurities Oct. 15, 2024
  • Patent Title: Reagent cartridge Oct. 15, 2024
  • Patent Title: Methods of amplifying circular polynucleotides in situ Oct. 08, 2024
  • Patent Title: Modified Oct. 08, 2024
  • Patent Title: Kinematic imaging system Sep. 24, 2024
  • Patent Title: Linked paired strand sequencing Sep. 03, 2024
  • Patent Title: Nucleic acid circularization and amplification on a surface Aug. 27, 2024
  • Patent Title: Flow cell carrier device Aug. 20, 2024
  • Patent Title: Compositions and methods for nucleic acid sequencing Aug. 13, 2024
  • Patent Title: Reducing agents and uses thereof Aug. 06, 2024
  • Patent Title: Methods and compositions for reducing nucleotide impurities Jul. 09, 2024
  • Patent Title: Spatial sequencing Jun. 11, 2024
  • Patent Title: Silicon containing detectable compounds and uses thereof May. 21, 2024
  • Patent Title: Nucleotide cleavable linkers and uses thereof Apr. 30, 2024
  • Patent Title: Multiport disconnect couplings Apr. 23, 2024
  • Patent Title: Nucleotide analogues Apr. 16, 2024
  • Patent Title: Cleavable disulfide linkers and uses thereof Apr. 02, 2024
  • Patent Title: Amplification oligonucleotides Mar. 19, 2024
  • Patent Title: Methods and compositions for sequencing complementary polynucleotides Feb. 27, 2024
  • Patent Title: Imaging systems and methods useful for patterned structures Feb. 13, 2024
  • Patent Title: Linked paired strand sequencing Feb. 06, 2024
  • Patent Title: Methods for in situ transcriptomics and proteomics Feb. 06, 2024
  • Patent Title: Modified pyrococcus polymerases and uses thereof Feb. 06, 2024
  • Patent Title: Nanoarrays and methods of use thereof Jan. 30, 2024
  • Patent Title: Engineered Jan. 30, 2024
  • Patent Title: Microplate assembly Jan. 30, 2024
  • Patent Title: Microplate assembly Jan. 30, 2024
  • Patent Title: Nucleotide analogues Jan. 23, 2024
  • Patent Title: Microplate Jan. 09, 2024
  • Patent Title: Amplification oligonucleotides Jan. 02, 2024
  • Patent Title: Modified Dec. 26, 2023
  • Patent Title: Modified Dec. 19, 2023
  • Patent Title: Lid for a reagent cartridge Dec. 05, 2023
  • Patent Title: Sample cartridge Nov. 21, 2023
  • Patent Title: Flow cell receiver and devices Nov. 14, 2023
  • Patent Title: Amplification oligonucleotides Oct. 31, 2023
  • Patent Title: Nucleic acid delivery scaffolds Oct. 24, 2023
  • Patent Title: Methods and compositions for sequencing complementary polynucleotides Oct. 17, 2023
  • Patent Title: Strip tube for a reagent cartridge Oct. 10, 2023
  • Patent Title: Nucleic acid sequencing-by-synthesis (sbs) methods that combine sbs cycle steps Oct. 03, 2023
  • Patent Title: Spatial sequencing Sep. 12, 2023
  • Patent Title: Flow cell carrier and methods of use Sep. 05, 2023
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of OMIC in WallStreetBets Daily Discussion

OMIC News

Recent insights relating to OMIC

CNBC Recommendations

Recent picks made for OMIC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in OMIC

OMIC Top Shareholders
Shareholder
Shares Held
OMIC Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

OMIC Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view OMIC Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top